FDA Panel Doubts Lumbar Fusion Alternative’s Imaging Data
This article was originally published in The Gray Sheet
Executive Summary
St. Francis Medical should collect more detailed radiographic data of its X-Stop non-fusion lumbar device to prove reduction of stenosis-induced pressure on spinal nerve roots, FDA panelists urged Aug. 31
You may also be interested in...
Ortho Panel Green Lights VertiFlex’s Superion Spine Spacer
A majority of FDA advisors say the device intended to treat lumbar spinal stenosis has a positive risk-benefit profile but should require an extended postmarket trial to evaluate its safety and efficacy over a longer time period.
St. Francis’ X-Stop Gets FDA Green Light To Treat Lumbar Spinal Stenosis
St. Francis Medical Technologies will begin marketing the X-Stop non-fusion device for lumbar spinal stenosis in January to experienced surgeons in order to build the product's reputation
St. Francis’ X-Stop Gets FDA Green Light To Treat Lumbar Spinal Stenosis
St. Francis Medical Technologies will begin marketing the X-Stop non-fusion device for lumbar spinal stenosis in January to experienced surgeons in order to build the product's reputation